BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li H, Jin H, Wan W, Wu C, Wei L. Cancer nanomedicine: mechanisms, obstacles and strategies. Nanomedicine 2018;13:1639-56. [DOI: 10.2217/nnm-2018-0007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Porter J, Ding Y, Hale SJM, Perrins RD, Robinson A, Mazanetz MP, Wu Y, Ma Y, Conlon K, Coulter T. A highly potent maytansinoid analogue and its use as a cytotoxic therapeutic agent in gold nanoparticles for the treatment of hepatocellular carcinoma. Bioorg Med Chem Lett 2020;30:127634. [PMID: 33148516 DOI: 10.1016/j.bmcl.2020.127634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Shahiwala A, Qawoogha SS, Tambuwala MM. Oral adjuvant therapy for colorectal cancer: recent developments and future targets. Ther Deliv 2019;10:659-69. [PMID: 31702443 DOI: 10.4155/tde-2019-0067] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Paramasivam G, Palem VV, Sundaram T, Sundaram V, Kishore SC, Bellucci S. Nanomaterials: Synthesis and Applications in Theranostics. Nanomaterials (Basel) 2021;11:3228. [PMID: 34947577 DOI: 10.3390/nano11123228] [Reference Citation Analysis]
4 Sztandera K, Gorzkiewicz M, Klajnert-maculewicz B. Gold Nanoparticles in Cancer Treatment. Mol Pharmaceutics 2019;16:1-23. [DOI: 10.1021/acs.molpharmaceut.8b00810] [Cited by in Crossref: 137] [Cited by in F6Publishing: 102] [Article Influence: 34.3] [Reference Citation Analysis]
5 Levit SL, Tang C. Polymeric Nanoparticle Delivery of Combination Therapy with Synergistic Effects in Ovarian Cancer. Nanomaterials (Basel) 2021;11:1048. [PMID: 33923947 DOI: 10.3390/nano11041048] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Tabish TA, Dey P, Mosca S, Salimi M, Palombo F, Matousek P, Stone N. Smart Gold Nanostructures for Light Mediated Cancer Theranostics: Combining Optical Diagnostics with Photothermal Therapy. Adv Sci (Weinh) 2020;7:1903441. [PMID: 32775148 DOI: 10.1002/advs.201903441] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 18.5] [Reference Citation Analysis]
7 Moradi Kashkooli F, Soltani M, Souri M, Meaney C, Kohandel M. Nexus between in silico and in vivo models to enhance clinical translation of nanomedicine. Nano Today 2021;36:101057. [DOI: 10.1016/j.nantod.2020.101057] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 12.0] [Reference Citation Analysis]
8 Li M, Wang Y, Jiang S, Gao Y, Zhang W, Hu S, Cheng X, Zhang C, Sun P, Ke W, Wang G, Song Z, Zhang Y, Zheng QC. Biodistribution and biocompatibility of glycyrrhetinic acid and galactose-modified chitosan nanoparticles as a novel targeting vehicle for hepatocellular carcinoma. Nanomedicine (Lond) 2020;15:145-61. [PMID: 31782335 DOI: 10.2217/nnm-2018-0455] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Azevedo A, Farinha D, Geraldes C, Faneca H. Combining gene therapy with other therapeutic strategies and imaging agents for cancer theranostics. Int J Pharm 2021;606:120905. [PMID: 34293466 DOI: 10.1016/j.ijpharm.2021.120905] [Reference Citation Analysis]
10 Luque-Michel E, Lemaire L, Blanco-Prieto MJ. SPION and doxorubicin-loaded polymeric nanocarriers for glioblastoma theranostics. Drug Deliv Transl Res 2021;11:515-23. [PMID: 33405212 DOI: 10.1007/s13346-020-00880-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Yan G, Huang Y, Li D, Xu Y, Wang J, Wang X, Tang R. Sequentially dynamic polymeric micelles with detachable PEGylation for enhanced chemotherapeutic efficacy. European Journal of Pharmaceutics and Biopharmaceutics 2019;145:54-64. [DOI: 10.1016/j.ejpb.2019.10.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
12 Sztandera K, Gorzkiewicz M, Klajnert-Maculewicz B. Nanocarriers in photodynamic therapy-in vitro and in vivo studies. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2020;12:e1509. [PMID: 31692285 DOI: 10.1002/wnan.1599] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
13 Zhang J, Wang X, Cheng L, Yuan J, Zhong Z. SP94 peptide mediating highly specific and efficacious delivery of polymersomal doxorubicin hydrochloride to hepatocellular carcinoma in vivo. Colloids Surf B Biointerfaces 2021;197:111399. [PMID: 33075660 DOI: 10.1016/j.colsurfb.2020.111399] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Mendes BB, Sousa DP, Conniot J, Conde J. Nanomedicine-based strategies to target and modulate the tumor microenvironment. Trends Cancer 2021;7:847-62. [PMID: 34090865 DOI: 10.1016/j.trecan.2021.05.001] [Reference Citation Analysis]
15 Yu W, Cheng Q, Ye J, Zhang M, Zhang C, Gao F, Ding X, Feng J, Zhang X. Establishment of Facile Nanomedicine Construction Methodology to Comprehensively Overcome Hurdles across Tumor‐Specific Nano‐Delivery. Adv Funct Mater 2020;30:2002239. [DOI: 10.1002/adfm.202002239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Dib S, Aggad D, Mauriello Jimenez C, Lakrafi A, Hery G, Nguyen C, Durand D, Morère A, El Cheikh K, Sol V, Chaleix V, Dominguez Gil S, Bouchmella K, Raehm L, Durand JO, Boufatit M, Cattoën X, Wong Chi Man M, Bettache N, Gary-Bobo M. Porphyrin-based bridged silsesquioxane nanoparticles for targeted two-photon photodynamic therapy of zebrafish xenografted with human tumor. Cancer Rep (Hoboken) 2019;2:e1186. [PMID: 32721109 DOI: 10.1002/cnr2.1186] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
17 Moradi Kashkooli F, Soltani M, Souri M. Controlled anti-cancer drug release through advanced nano-drug delivery systems: Static and dynamic targeting strategies. J Control Release 2020;327:316-49. [PMID: 32800878 DOI: 10.1016/j.jconrel.2020.08.012] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 14.5] [Reference Citation Analysis]
18 Kamal NAMA, Abdulmalek E, Fakurazi S, Cordova KE, Abdul Rahman MB. Surface peptide functionalization of zeolitic imidazolate framework-8 for autonomous homing and enhanced delivery of chemotherapeutic agent to lung tumor cells. Dalton Trans 2021;50:2375-86. [PMID: 33555001 DOI: 10.1039/d1dt00116g] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Yang C, Lin ZI, Chen JA, Xu Z, Gu J, Law WC, Yang JHC, Chen CK. Organic/Inorganic Self-Assembled Hybrid Nano-Architectures for Cancer Therapy Applications. Macromol Biosci 2021;:e2100349. [PMID: 34735739 DOI: 10.1002/mabi.202100349] [Reference Citation Analysis]